1. Home
  2. INFU vs IMRX Comparison

INFU vs IMRX Comparison

Compare INFU & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INFU
  • IMRX
  • Stock Information
  • Founded
  • INFU 2005
  • IMRX 2008
  • Country
  • INFU United States
  • IMRX United States
  • Employees
  • INFU N/A
  • IMRX N/A
  • Industry
  • INFU Medical/Dental Instruments
  • IMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INFU Health Care
  • IMRX Health Care
  • Exchange
  • INFU Nasdaq
  • IMRX Nasdaq
  • Market Cap
  • INFU 124.0M
  • IMRX 145.7M
  • IPO Year
  • INFU N/A
  • IMRX 2021
  • Fundamental
  • Price
  • INFU $5.70
  • IMRX $3.37
  • Analyst Decision
  • INFU Strong Buy
  • IMRX Strong Buy
  • Analyst Count
  • INFU 1
  • IMRX 4
  • Target Price
  • INFU $12.00
  • IMRX $13.25
  • AVG Volume (30 Days)
  • INFU 103.0K
  • IMRX 695.7K
  • Earning Date
  • INFU 08-11-2025
  • IMRX 08-12-2025
  • Dividend Yield
  • INFU N/A
  • IMRX N/A
  • EPS Growth
  • INFU 3654.89
  • IMRX N/A
  • EPS
  • INFU 0.15
  • IMRX N/A
  • Revenue
  • INFU $137,582,000.00
  • IMRX N/A
  • Revenue This Year
  • INFU $11.06
  • IMRX N/A
  • Revenue Next Year
  • INFU $7.86
  • IMRX N/A
  • P/E Ratio
  • INFU $37.97
  • IMRX N/A
  • Revenue Growth
  • INFU 7.98
  • IMRX N/A
  • 52 Week Low
  • INFU $4.61
  • IMRX $1.00
  • 52 Week High
  • INFU $9.97
  • IMRX $4.69
  • Technical
  • Relative Strength Index (RSI)
  • INFU 45.43
  • IMRX 43.79
  • Support Level
  • INFU $5.38
  • IMRX $3.42
  • Resistance Level
  • INFU $6.31
  • IMRX $4.69
  • Average True Range (ATR)
  • INFU 0.20
  • IMRX 0.31
  • MACD
  • INFU -0.01
  • IMRX -0.17
  • Stochastic Oscillator
  • INFU 50.79
  • IMRX 6.39

About INFU InfuSystems Holdings Inc.

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-reportable segment. The first is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second, Device Solutions, supports the Patient Services platform and leverages service orientation to win incremental business from its direct payer clients. The Device segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Majority from Patient.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: